摘要:
The present invention provides a non-naturally occurring High-Density Lipoprotein-like peptide-phospholipid scaffold (“HPPS”) nanoparticle. More particularly, the invention provides a non-naturally occurring peptide-lipid nanoscaffold comprising: (a) at least one phospholipid; (b) at least one unsaturated lipid, preferably an unsaturated sterol ester, further preferably an unsaturated cholesterol ester, further preferably cholsteryl oleate; and (c) at least one peptide, the peptide comprising an amino acid sequence capable of forming at least one amphipathic a-helix; wherein the components a), b) and c) associate to form the peptide-phospholipid nanoscaffold. In embodiments of the present invention, a cell surface receptor ligand is incorporated into the HPPS. In one embodiment, the cell surface receptor ligand is covalently bonded to the peptide scaffold of the HPPS nanoparticles. In other embodiments, a cell surface receptor ligand is coupled to a lipid anchor and is displayed on the surface of the HPPS nanoparticles by incorporation of the lipid anchor into the phospholipids monolayer of the HPPS nanoparticle. The present invention also provides pharmaceutical formulations comprising HPPS nanoparticles and methods of making the HPPS nanoparticles.
摘要:
The present invention relates to the field of conjugates comprising a substrate which is attached to at least one photoactivatable killing agent and at least one first quencher, and methods for their use. More particularly, the present invention relates to photodynamic therapy agents. The invention further relates to methods for decontaminating blood and methods for treating cancer or viral infection in a subject using the conjugates of the present invention.
摘要:
The present invention relates to the field of conjugates comprising a substrate which is attached to at least one photoactivatable killing agent and at least one first quencher, and methods for their use. More particularly, the present invention relates to photodynamic therapy agents. The invention further relates to methods for decontaminating blood and methods for treating cancer or viral infection in a subject using the conjugates of the present invention.
摘要:
The present invention relates to novel antineoplastic agents and cancer diagnostic agents that specifically target neo-plastic cells via the GLUT transportation system. More specifically, the invention relates to conjugates of 2-deoxyglucose, wherein a linker, which includes a covalent bond, is attached to 2-deoxyglucose at the 2 position, and the linker is attached to a therapeutic or diagnostic agent. The invention also relates to methods of treating tumor disease and methods of making the novel compounds of the present invention. The agents of the present invention are superior to previous agents as they are targeted via GLUT transporters.
摘要:
The present disclosure provides a passive optical network (PON) system and a method for protecting the service of the system for service recovery and fault locating in case of a failure of the network, wherein the PON system comprises an optical line terminal (OLT), an optical distribution network (ODN) and an optical network terminal (ONT) equipment protection group comprising a plurality of ONT equipment groups, each of which is connected to at least one of other ONT equipment groups within the ONT equipment protection group for the mutual protection relationship. The PON system of the present disclosure does not require equipment and link redundancy for backup, contributes to reduced cost and improved utilization of resources, and provides a means for diagnosing any faults of the links and equipment in the network.
摘要:
A method for processing Machine-to-Machine (M2M) platform services and a M2M platform are disclosed. The method comprises: receiving a service request sent by a terminal; selecting a corresponding application according to capacity required by the service request; and forwarding the service request to the corresponding application, and feeding back a response result of the application to the terminal. The method for processing M2M platform services and the M2M platform in accordance with the present implement a platform for providing a variety applications for users.
摘要:
The present disclosure provides a passive optical network (PON) system and a method for protecting the service of the system for service recovery and fault locating in case of a failure of the network, wherein the PON system comprises an optical line terminal (OLT), an optical distribution network (ODN) and an optical network terminal (ONT) equipment protection group comprising a plurality of ONT equipment groups, each of which is connected to at least one of other ONT equipment groups within the ONT equipment protection group for the mutual protection relationship. The PON system of the present disclosure does not require equipment and link redundancy for backup, contributes to reduced cost and improved utilization of resources, and provides a means for diagnosing any faults of the links and equipment in the network.
摘要:
There is herein described a nanovesicle comprising a bilayer of porphyrin-phospholipid conjugates. Each porphyrin-phospholipid conjugate comprises one porphyrin, porphyrin derivative or porphyrin analog covalently attached to a lipid side chain at one of the sn-1 or the sn-2 positions of one phospholipid. Further, the nanovesicle has a defined regioisomeric ratio of sn-1:sn-2 porphyrin-phospholipid conjugates.
摘要:
A method for processing Machine-to-Machine (M2M) platform services and a M2M platform are disclosed. The method comprises: receiving a service request sent by a terminal; selecting a corresponding application according to capacity required by the service request; and forwarding the service request to the corresponding application, and feeding back a response result of the application to the terminal. The method for processing M2M platform services and the M2M platform in accordance with the present implement a platform for providing a variety applications for users.
摘要:
The present invention relates to novel antineoplastic agents and cancer diagnostic agents that specifically target neoplastic cells via the GLUT transportation system. More specifically, the invention relates to conjugates of 2-deoxyglucose, wherein a linker, which includes a covalent bond, is attached to 2-deoxyglucose at the 2 position, and the linker is attached to a therapeutic or diagnostic agent. The inventions also relates to methods of treating tumor disease and methods of making the novel compounds of the present invention. The agents of the present invention are superior to previous agents as they are targeted via GLUT transporters.